Provigil: Subdued Prescriptions from Doctors - in Australia

Product description at a glance and signals indicating

Modafinil (brand example: Provigil) is a prescription medicine used to promote wakefulness in adults who suffer excessive daytime sleepiness. Common clinical signs that indicate include narcolepsy, persistent sleepiness associated with obstructive sleep apnea after optimised primary therapy, and shift work sleep disorder.

Tablets are typically available in 100 mg and 200 mg strengths. Although modafinil is sometimes mentioned in media as a cognitive enhancer, in Australia it is a regulated prescription drug, not a supplement.

Fast links: view all dosage directions, after effects or lawful status under Australian jurisdiction.

How does it work? in the brain

The exact molecular the operational mechanism of modafinil is not fully mapped, but its clinical effect stems from modulation of several neurotransmitter systems. Evidence suggests influence on dopamine transport, norepinephrine pathways, histaminergic neurons paired with the orexin/hypocretin system, resulting in improved alertness and reduced sleep propensity for many users.

Recommended dose and how to accept it

Follow the regimen prescribed by your clinician. Do not change the dose or stop treatment without medical advice. Common adult dosing patterns include:

• Standard adult dose: 200 mg once daily for many patients; some start at 100 mg and titrate upward if required.
• Timing: for narcolepsy and residual sleepiness from sleep apnea, take in the morning; for shift-work disorder take about one hour before the shift begins.
• Food: modafinil may be taken with or without meals. A meal can delay onset, but not necessarily reduce overall effect.
• Review: clinicians typically reassess benefit and tolerability after several weeks and again around three months to decide on ongoing need.

If your job involves safety-critical tasks, discuss timing and continuous monitoring with your prescriber involved. For safety recommendations see safety measures and avoid these items.

Situations that preclude therapy and pre-treatment checks

Do not take modafinil if you have had a serious hypersensitivity reaction to modafinil or armodafinil, including severe skin rash, swelling of the face or airway compromise.

Before you commence, tell your clinician about:

• Cardiac conditions: angina, prior myocardial infarction, arrhythmia or uncontrolled hypertension
• Significant liver disease or advanced kidney impairment
• A current or past history of psychosis, bipolar disorder, severe depression, or marked mood instability
• A history of substance misuse or dependence
• Pregnancy, planning for pregnancy, or breastfeeding.

Although rare, life-threatening skin and hypersensitivity reactions have been reported. If you notice a new rash, blisters, mouth ulcers, fever with sore throat, yellowing of the skin, difficulty breathing, or facial swelling, stop the medicine and seek urgent medical attention.

Missed dosing and overdose event response procedures

• Dose not administered: If you do not take a dose and your usual sleep time is approaching, skip the failure to take a dose. Do not double the dose to compensate for a failure to take a dose.
• Overdose incident: If overdose case is suspected, contact emergency services or your local poison information centre immediately for advice.

Hazard prevention tips and items to avoid

• Driving and machines: Do not drive or use heavy machinery until you know how modafinil affects your alertness and coordination.
• Alcoholic beverage product: Avoid alcohol while taking modafinil since unpredictable a reciprocal exchanges can be viewed as exchanges of the available information. may occur.
• Safety-critical roles: Discuss treatment with occupational health or your employer if you work in roles where alertness is essential; follow any workplace reporting rules.

For more on the process of interactions between people can shape outcomes. with other medicines and contraception, see how the mutual influence during contacts create opportunities for collaboration. affect contraception advice.

Short term effects and urgent warning signs

Seek immediate medical care for signs of a severe allergic reaction such as hives, facial or throat swelling, or breathing difficulty.

Stop modafinil and get urgent medical assessment if you develop any of the following:

• Severe new skin rash, blistering, peeling or severe mouth ulcers
• Fever with skin rash or sore throat
• Shortness of breath, chest pain, or an irregular heartbeat
• Jaundice (yellowing of skin or eyes), dark urine, or unexplained abdominal pain
• Marked psychiatric changes such as agitation, depression, suicidal thoughts, hallucinations or aggressive behavior

Common milder effects that often resolve include episodic headache, nausea, difficulty sleeping, nervousness, stomach discomfort, dizziness and nasal congestion. If symptoms persist or are troublesome, contact your prescriber.

Go to the head of this page

Pharmacologic contraception options alongside their the quality of collaborative interactions matters for trust. advice

Modafinil is an inducer of certain liver enzymes, notably some in the CYP3A4 family. This can reduce blood concentrations of medicines metabolised by those enzymes.

• Contraception: Modafinil may reduce the effectiveness of combined hormonal contraceptives (pills, patch, ring) and some implants. Use an additional barrier method while taking modafinil and for at least two months after stopping. Speak with your clinician about permanent or longer-acting contraceptive options if relevant.
• Other medicines: Tell your prescriber and pharmacist about antidepressants, antiepileptic drugs, anticoagulants, stimulants and any herbal or complementary products, as dose adjustments or status monitoring may be needed.

Nonconventional treatments with related medications

Choice of therapy depends on diagnosis, symptom severity, coexisting conditions and individual tolerance. Other possibilities clinicians may consider include:

• Armodafinil (example brand: Nuvigil) — a closely related medication with a slightly different duration of action.
• Methylphenidate — a stimulant option sometimes used for severe daytime sleepiness; side effect profile differs from modafinil.
• Dexamfetamine or lisdexamfetamine — central stimulants reserved for selected patients under careful supervision.
• Solriamfetol or sodium oxybate — other pharmacological options for particular symptoms; these may require specialist prescription and can have different costs and access entitlement rules located within Australia.
• Non-drug approaches — optimising sleep hygiene, effective use of CPAP for obstructive sleep apnea, and structured shift-work strategies can reduce medication need.

For athletes: modafinil is prohibited in-competition under anti-doping rules. See legal and sports regulation additional details are available.

Typical charges in Australia (AUD)

Out-of-pocket costs vary by brand, pack size, pharmacy and whether you qualify for Pharmaceutical Benefits Scheme (PBS) subsidy. Indicative private purchase ranges:

• Modafinil 100 mg, 30 tablets: approximately AUD 70 to 150 for private prescriptions.
• Modafinil 200 mg, 30 tablets: approximately AUD 90 to 180 for private prescriptions.
• Armodafinil (equivalent supply): often priced higher than generic modafinil; exact amounts vary by supplier.

If you meet PBS criteria (for example for defined narcolepsy signals indicating), the cost to you will normally be the PBS co-payment for general or concession patients. Prices change over time, so check with your pharmacist for current figures.

Legal condition and regulatory note summaries and references in Australia

• Prescription-only: Modafinil is Schedule 4 and requires a valid prescription across Australia. Possession or supply without a prescription is unlawful and may result in legal consequences under state or territory laws.
• PBS and authority: Subsidised access is restricted to specific clinical uses; prescribers may need to obtain authority approval to access PBS pricing approach for eligible patients.
• Personal importation: Under the TGA Personal Importation Scheme, an individual may import up to three months supply of a prescription medicine for personal use if they hold a current Australian prescription. Keep original packaging and a copy of the prescription in case of customs inspection.
• Driving and safety roles: Even when treated, a person should not drive or operate heavy machinery if they remain excessively sleepy. Some states may require notification of licensed drivers with certain sleep disorders; check local requirements.
• Sport and anti-doping compliance: Modafinil is prohibited in-competition by the World Anti-Doping Code. Athletes must obtain an approved Therapeutic Use Exemption (TUE) before competing. Contact Sport Integrity Australia or your sport organisation for current advice.
• Off-label use: Clinicians may prescribe modafinil off-label in specific situations, but any dispensing still requires a prescription and clinical justification.

For authoritative and current guidance consult the Therapeutic Goods Administration (TGA), state and territory health regulators, or your treating health professionals. Navigate back to the page's top